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Abstract
Sepsis and septic shock are life-threatening conditions that remain an enormous 
burden of morbidity and mortality to millions of patients globally and cause organ 
dysfunction, leading to death in as many as one in four patients, often even more. 
Early management and appropriate treatment are essential to improve outcomes 
and reduce morbidity and mortality. In 2016, the Third International Consensus 
Definition for Sepsis and Septic Shock (Sepsis-3) defined sepsis as life-threatening 
organ dysfunction resulting from dysregulated host responses to infection, and defined 
septic shock as a subset of sepsis in which underlying circulatory, cellular, and metabolic 
abnormalities are profound enough to substantially increase the risk of mortality. That 
same year the group also implemented the application of the sequential organ fail-
ure assessment (SOFA) score over the systemic inflammatory response syndrome 
(SIRS) score. Sepsis in pregnancy remains a leading cause of maternal morbidity 
and mortality worldwide, with no current standard definition for severe sepsis 
for the pregnant or peripartum woman. The prevalence of pediatric septic shock 
is on the rise and brings with it the consequences of long-term morbidity and also 
death. Since the advent of programs for early recognition and treatment, mortality 
has decreased. Even so, globally, many children succumb to septic shock despite 
evidence-based care and years of research.
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1. Introduction
Sepsis and septic shock are life-threatening conditions that remain an enormous 
burden of morbidity and mortality to millions of patients globally and cause organ 
dysfunction, leading to death in as many as one in four patients, often even more 
[1]. Early management and appropriate treatment are essential to improve out-
comes and reduce morbidity and mortality.
Sepsis is a multifaceted disorder, developing from a dysregulated response by 
the host to an infectious nidus, and is associated with acute organ dysfunction and a 
high risk of mortality.
The incidence of sepsis is high, and remains one of the leading causes of death 
worldwide [2]. The reported incidence is increasing, which is likely a reflection on 
the older population with more comorbidities. Even though incidence is not known, 
estimates indicate that sepsis is a leading cause of morbidity and mortality globally. 
Even though sepsis is a deadly disease, data now shows the after effects of sepsis to 
be quite traumatic; often showing long term physical, physiological and cognitive 
disabilities [3].
Over the past 30 years, with the help of an extensive amount of research and 
better-quality clinical processes, the treatment and recognition of sepsis has 
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happened at a faster pace [2]. At the World Health Assembly in 2017, the World 
Health Organization (WHO) made sepsis a global health priority and passed a 
resolution to improve the prevention, diagnosis and management of sepsis [4].
In this chapter, we will examine the current definitions of sepsis and septic 
shock. We will explore the current guidelines in the diagnosis of sepsis. As we delve 
into the diagnosis, we will discuss the pathophysiology, clinical presentation, risk 
factors, etiologies, and finally, management strategies and treatments of the adult, 
pregnant and pediatric populations.
2. Sepsis and septic shock in adults
2.1 Definitions of sepsis and septic shock
The first definition of sepsis, published in 1992, was based on the presence of a 
suspected or proven infection with two or more criteria of the systemic inflamma-
tory response syndrome (SIRS) [5]. Sepsis was defined, as the presence of two or 
more positive SIRS criteria with a confirmed or suspected infection as the underly-
ing cause. If signs of organ dysfunction were seen, the diagnosis was changed to 
severe sepsis. Septic shock was defined by the presence of acute circulatory failure 
and arterial hypotension along with features of sepsis. Until recently, the defini-
tions of sepsis, septic shock and organ dysfunction remained the same for more 
than 20 years (Figure 1). Due to the inaccuracies of the past definition and the SIRS 
criteria, new guidelines were published by the surviving sepsis campaign (SSC) in 
2016, a multidisciplinary task force started by the Society of Critical Care Medicine 
in the United States and the European Society of Intensive Care Medicine [6, 7]. 
Since there is no gold standard test for sepsis, the task force decided to come up 
with definitions and clinical criteria that were clear, useful, and valid [3]. Instead 
of using the SIRS criteria to determine if a patient is in going into sepsis, the new 
guidelines suggest using the sequential organ failure assessment (SOFA) score and 
a quick SOFA score for more emergent cases, a topic that will be discussed in length 
in the next section.
In 2016, the Third International Consensus Definition for Sepsis and Septic 
Shock (Sepsis-3) defined sepsis as a life-threatening organ dysfunction resulting from 
dysregulated host responses to infection, and defined septic shock as a subset of sepsis 
in which underlying circulatory, cellular, and metabolic abnormalities are profound 
enough to substantially increase the risk of mortality (Table 1) [2]. Septic shock is 
also defined as persisting hypotension that requires vasopressors to achieve a mean 
arterial pressure ≥65 mmHg despite adequate fluid resuscitation and a lactic acid level 
>2 mmol/L [7]. These new definitions focused on organ dysfunction rather than 
inflammation.
2.2 SIRS versus SOFA
The same task force that changed the definition also implemented the use of 
the sequential organ failure assessment (SOFA) score over the SIRS criteria. Even 
though SOFA is not considered the gold standard for diagnosis, its use is recom-
mended over SIRS.
SIRS was based on an inflammatory response to an infectious inoculation 
(Figure 2). Throughout its utilization, the surviving sepsis guidelines, specifi-
cally the SIRS criteria, were widely criticized. Many thought the definition was 
not helpful largely because the definition place a large emphasis on inflammation, 
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causing many patients without bacterial or viral infections to receive empiric 
antibiotic therapy and over-resuscitation [10]. The SIRS criteria were also thought 
to be remarkably sensitive, not taking into account any outside factors, multi-drug 
resistance and the ability to attain source control [3]. Based on the old definition of 
sepsis using the SIRS criteria, patients may have been incorrectly identified as being 
septic. One study showed a positive SIRS score in 87% of all ICU admissions, yet 
14.3% of those with 2 or more SIRS criteria did not have infection [5, 7]. Moreover, 
in another study, 12.1% of patients had SIRS-negative sepsis, which is approxi-
mately a miss of 1 in 8 patients diagnosed with sepsis [11].
Due to these inaccuracies in the SIRS criteria, the new Sepsis-3 definitions 
recommend using the SOFA score; however, it is not commonly used or known 
outside of the critical care world [7]. The SOFA score is an aggregate score, 
from 0 to 4, for each organ system, including respiratory, coagulation, liver, 
cardiovascular, renal and central nervous systems [12]. An acute increase in the 
total score of 2 or more reflects an overall mortality risk in patients suspected of 
infection [7]. Calculating the SOFA score at the bedside or in a noncritical care 
unit and in patients who do not have full laboratory testing, is challenging. Since 
the SOFA score is based on biochemical criteria, the task force developed the 
clinical qSOFA screening tool which is based on respiratory rate, systolic blood 
pressure and altered mental state (Figure 2) [13]. If 2 of the 3 clinical variables 
Figure 1. 
Sepsis and septic shock definitions over the years [9]. Abbreviations: SIRS, systemic inflammatory response 
syndrome; SOFA, sequential organ failure assessment; and qSOFA, quick sequential organ failure assessment.
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are positive, the predictive validity is similar to the entire SOFA score when used 
outside the ICU setting [14].
2.3 Pathophysiology
Sepsis is a clinical syndrome with an array of disease courses of which is not 
completely understood. It is characterized by a varied response to infection, started 
Temperature > 38.3°C or <36.0°C
Heart rate > 90 beats/min
Respiratory rate > 20 breaths/min or 
PaCO2 < 32 mmHg
White blood cell count < 
4000 cells/mm3 or > 12,000 cells/mm3
Greater than 10% bandemia
SIRS Criteria
Must have 2 or more to meet 
positive criteria for SIRS
qSOFA Score
Must have 2/3 to be considered 
positive
Respiratory Rate > 22 breaths/min
Systolic blood pressure < 100 mmHg
Altered mental state/ Glasgow Coma 
Scale < 13
Figure 2. 
Comparison of SIRS versus qSOFA [7, 13, 15]. Abbreviations: SIRS, systemic inflammatory response syndrome; 
SOFA, sequential organ failure assessment; and qSOFA, quick SOFA.
Sepsis-3 new terms and definitions
• Sepsis is defined as life threatening organ dysfunction caused by dysregulated host responses to 
infection.
• Organ dysfunction can be identified as an acute change if you have ≥2 points on the SOFA score in 
relation to an infection
• Baseline SOFA score can be assumed to be zero in patients with no preexisting organ dysfunction and a 
score of ≥2 reflects an overall mortality risk of approximately 10% in a general hospital population with 
suspected infection.
• Layman terms—sepsis is a life-threatening condition that arises when the body’s response to an infec-
tion injures its own tissues and organs.
• Patients with suspected infection who are likely to have a prolonged ICU stay or to die in the hospital 
can be identified at the bedside with qSOFA (altered mental status, respiratory rate >22, systolic blood 
pressure <100 mmHg).
• Septic shock is a subset of sepsis in which underlying circulatory and cellular/metabolic abnormalities 
are severe enough to increase mortality.
• Patients with septic shock have preexisting sepsis with persisting hypotension requiring vasopressors 
to maintain MAP ≥ 65 mmHg and having a serum lactate level >2 mmol/L despite adequate volume 
resuscitation.
Abbreviations: MAP, mean arterial pressure; qSOFA, quick SOFA; SOFA, sequential [8] organ failure assessment; 
and ICU, intensive care unit.
Table 1. 
Sepsis-3 terms and definitions [3, 6].
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by recognition of pathogen associated molecular patterns (PAMPs) from invasive 
microorganisms [16]. PAMPs are conservative antigens that are recognized by 
four classes of receptors: Toll-like receptors, C-type lectin receptors, retinoic acid 
inducible gene 1-like receptors and nucleotide-binding oligomerization domain-like 
receptors [17]. Cell lysis and spillover of intracellular molecules into the extracel-
lular space is seen due to the resulting inflammatory response to the pathogen. The 
net result is an increased capillary permeability and vasodilation leading to hypo-
tension that results in tissue hypo-perfusion [16].
In sepsis, a hypercoagulable state is achieved due to the changes in the clot-
ting factors. There is an increase of tissue factor which causes a decrease of anti-
thrombin, subsequently causing an increase in plasma thrombin. At the same time 
there is decreased production of protein C and an increase in plasminogen activator 
inhibitor type 1 which all inhibits fibrinolysis. Increased coagulation and hypoten-
sion in sepsis can lead to multi organ failure, the most severe and life threatening 
consequence of sepsis [18]. During severe sepsis, and altered coagulation is almost 
always seen leading to disseminated intravascular coagulation (DIC). The mecha-
nisms of how cell injury and sepsis-induced organ dysfunction occur are not fully 
understood and continue to be an ongoing investigation [2].
2.4 Etiology
Sepsis can be caused by any type of infecting organism and can originate 
from communities, hospitals or other health care facilities [2]. The most common 
culprit is pneumonia, which accounts for about half of all cases, followed closely 
by intra-abdominal infections and urinary tract infections [19]. The most common 
gram positive bacteria seen are Staphylococcus aureus and Streptococcus pneumoniae, 
whereas Escherichia coli, Klebsiella species, and Pseudomonas aeruginosa are the most 
common gram-negative bacteria seen [20].
2.5 Risk factors
Most risk factors for sepsis mainly rely on the patient’s predisposition to infec-
tion. The main groups of patients are but not limited to; young or old age, patients 
with immunosuppressive diseases (e.g., AIDS) or ones taking immunosuppressive 
medications, cancer patients, alcoholics, patients with indwelling catheters, or other 
patients that have altered skin integrity all predispose them to infection [2, 21]. Age, 
sex, race, or ethnic groups have an influence on the incidence of severe sepsis. It is 
seen that sepsis mainly occurs in infants and elderly people, in males and African 
Americans rather than females Caucasians respectively [19, 22].
2.6 Clinical presentation
In sepsis, a person’s response to an infection presents as signs of infection 
together with acute organ dysfunction, which can lead to multiple organ failure, 
acidosis, and death [21]. The clinical manifestations of sepsis varies, depending on 
the where the infection happens, the type of organism, the pattern of acute organ 
dysfunction, the health status of the patient, and what happens prior to initiation 
of treatment. Acute organ dysfunction is most commonly seen in the respiratory 
and cardiovascular systems. Respiratory compromise is classically manifested as 
acute respiratory distress syndrome (ARDS), which is defined as hypoxemia with 
bilateral infiltrates of noncardiac origin. Cardiovascular compromise is manifested 
primarily as hypotension or an elevated serum lactate level [18]. Patients often 
present to the emergency department with general malaise, fever, tachycardia, 
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tachypnea, or altered mental status. Health professionals should look at lactate 
levels, white blood cell counts (leukocytosis or leukopenia), increases in plasma 
C-reactive protein or procalcitonin concentrations to help determine if a patient is 
becoming septic [2].
2.7 Clinical significance of lactate production
Lactate production in sepsis is multifactorial and incompletely understood. 
Most patients with sepsis and elevated lactate have a hyperdynamic circulation with 
adequate oxygen delivery. The source of lactate production is from the rapid rate of 
glycolysis and increased anaerobic production that does not always take place in the 
muscle, so other tissues/cells are possible major contributors. Its greatest utility is as 
a guide to therapeutic response, an indicator of severity, and a prognostic tool for 
mortality [7].
2.8 Management/treatment
The management and treatment of sepsis and septic shock should be dealt with 
as a medical emergency. Screening patients for signs and symptoms of sepsis and 
septic shock helps to identify and intervene when needed [21]. Proper treatment 
should focus on when to intervene and being able to find the source of the infection. 
An important part of the initial management of sepsis is to make sure there is an 
aggressive assessment to identify unknown sources of infection using appropriate 
laboratory testing and diagnostic imaging [2]. In addition, early initiation of appro-
priate antimicrobial therapy after blood cultures have been taken, restoring tissue 
perfusion by administering the proper amount of fluids, and advanced interven-
tions guided by assessment of the adequacy of resuscitation and resolution of organ 
dysfunction should be part of the initial sepsis management [21, 23].
The surviving sepsis campaign (SSC) issued guidelines for the management of 
sepsis and septic shock. It is divided into two sections: an initial management sec-
tion and a management section. The initial management section indicates what to 
do within the first 6 h after the patient presents with signs and symptoms that imply 
sepsis, and the management section indicates what to do when the patient is trans-
ferred to the ICU. The main points of the initial management section is to make sure 
that cardiorespiratory resuscitation takes place and to make sure that the immediate 
threats of infection have been controlled. Intravenous fluids and vasopressors are 
used to resuscitate the patient and oxygen therapy and mechanical ventilation are 
used if needed [18]. For patients with hemodynamic instability, as defined by either 
hypotension (systolic blood pressure <90 mmHg, MAP <70 mmHg, or a decrease in 
systolic blood pressure of >40 mmHg from baseline) or elevated lactate concentra-
tion (≥4 mmol/L), the SSC recommends rapid administration of 30 mL/kg crystal-
loid fluids started within the first hour [21, 24].
To determine the type of empirical antibiotic therapy needed, many factors are 
considered before choosing the initial therapy; the suspected site of infection, the 
setting where the infection developed, medical history, and local microbial-suscep-
tibility patterns. There is an increased chance of death if the improper therapy is 
chosen of if there is a delay in treatment, so intravenous broad spectrum antibiotics 
should be started immediately to cover all pathogens until sensitivity of the blood 
culture comes back [25]. The 2017 SSC recommendations state that IV antimicro-
bials should be started immediately, the initial choice should be broad spectrum 
coverage and the antibiotic spectrum should be narrowed when pathogens have 
been isolated and sensitivities have been established. A decrease in antibiotic usage 
should be considered when the patient’s condition improves [26].
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Septic shock is a consequence of sepsis and one of the criteria to determine if 
the patient is in septic shock is if the patient is hypotensive and requires vasopressor 
therapy even if adequate fluids have been administered [27]. In patients with septic 
shock, vasopressor therapy is often needed to help maintain perfusion pressure [2]. 
The first-line vasopressor recommended in septic shock is norepinephrine, based on 
multiple randomized controlled studies and meta-analysis comparing dopamine and 
norepinephrine. Use of norepinephrine was found to be superior with regard to mor-
tality and adverse cardiac events [28]. Epinephrine has potent inotropic and vasocon-
strictive effects, but is less commonly used as a first-line agent in septic shock, which 
is typically associated with a hyperdynamic circulation [7]. Vasopressin reduces the 
dose of catecholamine vasopressors, but does not appear to affect patient mortality 
[2]. It is often used as a replacement dose after initiation of norepinephrine [29].
3. Sepsis and septic shock in obstetrics
3.1 Introduction
Sepsis during pregnancy remains a leading cause of maternal morbidity and 
mortality worldwide [30]. In the USA, infection accounted for 14% and sepsis 4.3% 
of all maternal deaths between 2006 and 2010. In the UK between 2006 and 2012, 
genital tract sepsis accounted for 7% of all maternal deaths [8]. Even with advances 
in hygiene and antibiotic use, sepsis still accounts for 15% of maternal deaths a year 
worldwide. Due to inadequate resources and improper hygiene, it is mainly seen in 
low-income countries that maternal death is 3 times higher compared to high-income 
countries [31]. The failure to recognize sepsis and institute prompt treatment under-
lies most cases of maternal sepsis with poor outcomes. Pregnant women are at higher 
risk of developing infection due to the physiological changes that take place along 
with possible trauma and surgical interventions. These infections can go unnoticed 
until there is substantial clinical deterioration. The initial alteration of hemodynamics 
may be falsely attributed to labor pain or blood loss subsequent to delivery. Normal 
laboratory values in pregnant patients are different compared to the non-pregnant 
population. The definitions and criteria used to determine if a patient is in sepsis 
has not been fully investigated in pregnancy. There are currently efforts taking place 
to help implement early warning systems and revise the definition of sepsis to help 
diagnose sepsis earlier in a pregnant patient. It has been shown that early recognition, 
diagnosis and management of maternal sepsis lead to better maternal and fetal out-
comes [9]. Overall, diagnosing sepsis in a pregnant woman can be very difficult due 
to differing normal values. In this section we will go over causes, clinical presentation, 
diagnosis and treatment for sepsis and septic shock during pregnancy.
3.2 Definition of sepsis during pregnancy
Compared to the non-pregnant population, there is currently no standard 
definition for severe sepsis for pregnant and peripartum women [32]. There are 
multiple physiological changes that occur in an obstetric patient during the antepar-
tum and postpartum periods, which can make it difficult to identify if the patient is 
going into sepsis using the qSOFA scoring system.
3.3 Identification and scoring systems in pregnancy
Sepsis is something can occur at any time during one’s pregnancy and can even hap-
pen during the postpartum period, something that everyone should be aware of [33]. 
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During pregnancy, sepsis generally still follows the same rules versus a non-pregnant 
person, but it can be difficult to determine if a pregnant woman is in sepsis due to the 
changes in the baseline normal lab values seen; a non-pregnant patient’s normal lab 
values are different compared to a pregnant patient’s normal lab values. The physi-
ological changes of pregnancy overlap with hemodynamic changes associated with the 
initial presentation of sepsis [9]. Before 2016, the SIRS criteria were the main source to 
diagnose a pregnant patient. The pitfalls with the SIRS criteria were that physiologic 
maternal lab values would almost result in a diagnosis of SIRS. During pregnancy, the 
maternal heart rate is often >100, usually due to intravascular volume changes, PCO2 is 
normally at 32–34 mmHg, and WBC commonly increases to 14,000 or even as high as 
30,000, usually secondary to adrenocorticoid-mediated leukocytosis. After the Society 
of Critical Care Medicine redefined its criteria via the Sepsis-3 model, a qSOFA score 
was used instead of SIRS. As mentioned before, this score included three important 
points: altered mental status, hypotension (systolic <100 mmHg) and tachypnea (respi-
ratory rate > 22). In terms of the qSOFA and SOFA score, there continues to be a struggle 
to reach a clear cut definition for pregnant patients. Due to their normal lab values, it 
makes it difficult to diagnose a pregnant patient with sepsis using the current defini-
tions. For example, many patients have systolic blood pressures that are <100 mmHg 
and they are in no distress or their respiratory rate will increase with movement due to 
the extra effort it takes because of the large uterus, mainly during the third trimester 
[15]. With that being said, the diagnosis of sepsis during pregnancy is currently being 
made based on clinical suspicion, with a greater emphasis on signs of organ dysfunction 
rather than infection when determining the timing of intervention [33].
In the last decade, there has been development of early warning scoring systems 
to help identify septic patients at risk for poor outcomes. Unfortunately, many of 
these systems have not shown much use in the maternal population, such as the 
Modified Early Warning System (MEWS). These systems do not take into account 
the physiological changes that occur during pregnancy, something that overlaps 
with clinical criteria for diagnosing sepsis in the general population. Even though 
there is a high recommendation to develop maternal warning systems, there has 
been clear evidence that shows a lack of outcome benefit and validation studies have 
shown high sensitivity but low specificity. There needs to be further work done to 
improve the ability of the early warning systems to improve their ability to predict 
those with signs of early sepsis and at risk of deterioration. A major factor, that is, 
delaying the development is deciding which vital signs to use and what values are a 
sign of normality in the obstetric population [9].
Due to the inconsistencies in defining maternal sepsis, there are delays in diagnosis 
and treatment, something that can prove to be deadly to the pregnant population [15].
3.4 Immunological changes during pregnancy
During pregnancy, the maternal immune system will go through changes that 
will help protect the fetus from the maternal inflammatory response. There is 
downregulation of cell-mediated immunity, with decreased T-cell activity second-
ary to a decrease in numbers or reduction in the CD4/CD8 ratio, with an intact or 
upregulated humoral response to balance this change. Because of these changes, 
there is an increased chance to develop certain infections, such as Listeria, and more 
severe manifestations of some viral and fungal infections [34].
3.5 Risk factors of sepsis during pregnancy
Several risk factors have been identified during pregnancy, leading to the devel-
opment of guidelines to help prevent sepsis in this patient population [9]. There 
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are many reasons that sepsis can occur during pregnancy and postpartum. The 
pregnant woman can develop the same type of infections as in the non-pregnant 
population, but since there is a decrease in cell-mediated immune response, the 
infection can cause a more severe response. It is now routine to screen and treat 
asymptomatic bacteriuria and sexually transmitted diseases in early pregnancy and 
to administer antibiotic prophylaxis for cesarean deliveries [9, 35].
A woman can develop an infection at many sites during the course of her 
pregnancy. One common area is the genitalia, where urinary tract infections are 
very common due to the high levels of progesterone [32]. An untreated or improp-
erly treated urinary tract infection can lead to pyelonephritis, a common severe 
infection that occurs during pregnancy. It usually affects the right kidney, because 
of compression of the pregnant uterus, with offending organisms similar to non-
pregnant patients, E. coli being the major pathogen [32].
Chorioamnionitis is another cause of serious obstetric infection and is associ-
ated with increased risk of premature delivery and neonatal sepsis. The infection 
usually starts from the cervicovaginal area, and migrates to the amnion, decidua, 
and amniotic fluid. The infection is typically polymicrobial; commonly consisting 
of genital Mycoplasma, Streptococcus agalactiae and Escherichia coli. Risk factors for 
infection include prolonged labor, membrane rupture, digital vaginal examinations, 
young age, and alcohol use [32].
Pneumonia, which is associated with a high rate of morbidity and mortality 
compared to the non-pregnant population, may be caused by a bacterial, viral or 
fungal organism. The most common pneumonia pathogens seen in pregnancy are 
Varicella and Influenza A and B. Acute respiratory distress syndrome (ARDS) is a 
possible outcome due to respiratory infections in pregnancy [31].
Other risk factors include obesity, caesarean section, prolonged rupture of mem-
branes, mastitis, poor nutrition, chronic hypertension, anemia, lack of prenatal 
care, immunosuppression, and diabetes mellitus [36]. All of these risk factors can 
cause sepsis and eventually lead to septic shock in the pregnant population.
3.6 Causative organisms of sepsis during pregnancy
The major contributor to sepsis during pregnancy is group A streptococcus (GAS). 
It spreads directly through contact with open skin sores, perineal contamination or by 
mucus or droplet contamination. Group B streptococcus can cause urosepsis, endo-
metritis, mastitis, wound infections and meningitis [37]. In urinary tract infections 
during pregnancy, Escherichia coli is the most common pathogen, and if left untreated, 
it can lead to sepsis. S. aureus, E. coli, and anaerobes are common causes of bacteremia 
after cesarean section. Listeria monocytogenes is more classically associated with fetal 
loss [31]. HIV, AIDS, Pneumocystis carinii pneumonia, tuberculosis, and malaria are 
significant causes for maternal sepsis in low and middle income countries [38].
3.7 Management and treatment of sepsis during pregnancy
Even though the obstetric population were not specifically considered when 
the Surviving Sepsis Program were making the guidelines for treatment, those 
guidelines can still be used as a basis for treatment of sepsis and septic shock [21]. 
Early recognition of sepsis is associated with improved mortality and outcome. In 
a young, healthy pregnant patient, it may be difficult to identify sepsis and a delay 
in treatment may occur. With that being said a few warning signs to be considered 
that may alert severe sepsis include fever or hypothermia, tachycardia, tachypnea, 
diarrhea, vaginal discharge, leukopenia or leukocytosis, elevated lactate, metabolic 
acidosis, thrombocytopenia, or other manifestations of coagulopathy [39].
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Pregnant women who develop sepsis are usually infected with multiple organ-
isms. The initial choice of antibiotic should have broad spectrum coverage and base 
it off of guidelines and patterns of resistance [40]. The initial treatment should 
include coverage against Group A Streptococcus and Escherichia coli because they 
are the most common contributors to sepsis in pregnancy and responsible for a 
significant proportion of deaths [9].
In a septic pregnant patient, one big challenge is being able to manage fluids. The 
SSC guidelines recommend crystalloid at an initial 30 mL/kg bolus. This recom-
mendation can be too aggressive in the obstetric population, but there is evidence 
that shows balanced crystalloid solutions are associated with a lower mortality in 
sepsis as compared to normal saline [42].
Vasopressors can be used in sepsis mediated hypotension and septic shock. If 
hypotension does occur, the surviving sepsis campaign (SCC) recommends norepi-
nephrine as the first line agent. These SCC guidelines are based on evidence from 
non-pregnant patients and there is little data on the effect that vasopressors have on 
placental blood flow in a pregnant woman [9].
4. Sepsis and septic shock in pediatrics
4.1 Introduction
The prevalence of pediatric septic shock, causing death and long term mobility, has 
increased over the years, and prior to implementation of early recognition programs 
and treatment, mortality remained unchanged [43, 44]. Even with millions of dollars 
being spent and years of research being done, many children still suffer from septic 
shock [45]. Morbidity in children following severe sepsis is now similar to that in criti-
cally ill adults [46]. Due to the high rates of morbidity, mortality and costs associated 
with pediatric sepsis, there is an increased burden on healthcare communities [47]. 
As reported by Watson et al., pediatric sepsis patients had an average hospital stay of 
31 days and about 2 billion dollars are spent a year for their care [48]. The mainstays of 
pediatric sepsis treatment, according to the international guidelines, is prompt admin-
istration of antibiotics, rapid resuscitation and supportive care of organ dysfunction [1].
Adults and children differ in physiology, predisposing diseases, and sites of 
infection which necessitates differing diagnostic criteria and management strate-
gies [49]. Among children who develop sepsis worldwide, 49% have a comorbid 
condition that leaves them vulnerable to infection. The most common comorbidities 
in children who develop sepsis are age specific; infants have chronic lung disease 
or congenital heart disease, while children ages one through nine have underlying 
neuromuscular disease and adolescents have pre-existing cancer [50].
4.2 Diagnosis
The definition of adult sepsis has undergone continuing revision to keep pace 
with the high volume of published research; however, it is only recently that atten-
tion has been given to the pediatric patient and the many caveats that separate the 
pediatric patient from the adult. Prior to 2005, there was not a standard definition 
for pediatric sepsis which resulted in a lack of uniformity among sepsis studies [49]. 
In 2005, the Pediatric Sepsis Consensus Congress (PSCC) met to standardize the 
definition of sepsis. Defining sepsis in the pediatric patient is made more difficult 
due to age specific vital signs, and their tremendous physiologic reserve which often 
masks the seriousness of their condition. The PSCC divided age into six distinct 
categories in order to take into account age specific vital signs as well as age specific 
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risk factors for invasive infections which in turn affect antibiotic coverage guide-
lines [51]. Pediatric severe sepsis is defined as two or more systemic inflammatory 
response syndrome criteria, confirmed or suspected invasive infection, and cardio-
vascular dysfunction, acute respiratory distress syndrome, or two or more organ 
dysfunctions. Determination of altered physiology is specific to age dependent vital 
signs [49, 52]. At present, there is no single biomarker that has proven specific or 
sensitive enough to diagnose sepsis or prognosticate outcome in selected cohorts. 
Similar to studies of sepsis in adults, there is active research examining both clinical 
and research measurements applicable to a pediatric population [49].
4.3 Management
The current guidelines for treatment are summarized in the pediatric section of 
the surviving sepsis campaign (Figure 3) [49]. Early and aggressive source control 
Figure 3. 
Survive sepsis campaign pediatric treatment protocol [21].
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should be a top priority; this includes drainage, debridement, and surgical interven-
tion. Empiric antibiotic therapy should be administered within 1 hour of clinical 
suspicion and can be administered IV, IM or PO; antibiotics should not be delayed 
for blood cultures but every attempt should be made to obtain blood cultures prior 
to the first dose of antibiotics. Fluid resuscitation should be aggressive and admin-
istered as boluses of 20 mL/kg crystalloid given over 5–10 min via intravenous or 
intraosseous access. Early and aggressive fluid resuscitation has been shown to 
decrease mortality [21].
5. Conclusion
Sepsis and Septic Shock continue to be a growing concern in the world. Even 
though there is no current gold standard to diagnose sepsis and septic shock, the 
new guidelines allow the healthcare professional to determine if the patient could 
possibly go into sepsis and septic shock. The new guidelines help identify sepsis 
at an early stage in the adult population, but still show concerns in the pregnant 
and pediatric population. Due to the different normal lab values in a pregnant 
patient, SOFA cannot be accurately used to diagnose a patient. Defining sepsis in 
the pediatric patient is made more difficult due to age specific vital signs, and their 
tremendous physiologic reserve which often masks the seriousness of their condi-
tion. Sepsis and septic shock can be very deadly and the health care professional 
should be aware of the determining factors in the non-pregnant, pregnant and 
pediatric populations.
Acknowledgements
Funding for this manuscript was provided by The Everest Foundation.
© 2019 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms 
of the Creative Commons Attribution License (http://creativecommons.org/licenses/
by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, 
provided the original work is properly cited. 
13
Sepsis and Septic Shock
DOI: http://dx.doi.org/10.5772/intechopen.86800
[1] Rhodes A et al. Surviving sepsis 
campaign: international guidelines 
for management of sepsis and septic 
shock: 2016. Intensive Care Medicine. 
2017;43(3):304-377
[2] Cecconi M et al. Sepsis and septic 
shock. Lancet. 2018;392(10141):75-87
[3] Singer M et al. The third 
international consensus definitions 
for sepsis and septic shock (Sepsis-3). 
JAMA. 2016;315(8):801-810
[4] Reinhart K et al. Recognizing 
sepsis as a global health priority—A 
WHO resolution. The New 
England Journal of Medicine. 
2017;377(5):414-417
[5] Vincent JL et al. Sepsis in European 
intensive care units: Results of the 
SOAP study. Critical Care Medicine. 
2006;34(2):344-353
[6] J AC, Pinheiro I, Menezes Falcao L.  
Rethinking the concept of sepsis and 
septic shock. European Journal of 
Internal Medicine. 2018;54:1-5
[7] Gotur DB. Sepsis in a panorama: 
What the cardiovascular 
physician should know. Methodist 
DeBakey Cardiovascular Journal. 
2018;14(2):89-100
[8] Abir G et al. Clinical and 
microbiological features of maternal 
sepsis: A retrospective study. 
International Journal of Obstetric 
Anesthesia. 2017;29:26-33
[9] Burlinson CEG et al. Sepsis in 
pregnancy and the puerperium. 
International Journal of Obstetric 
Anesthesia. 2018;36:96-107
[10] Shankar-Hari M et al. Judging 
quality of current septic shock 
definitions and criteria. Critical Care. 
2015;19:445
[11] Kaukonen KM, Bailey M, Bellomo 
R. Systemic inflammatory response 
syndrome criteria for severe sepsis. 
The New England Journal of Medicine. 
2015;373(9):881
[12] Vincent JL et al. The SOFA (sepsis-
related organ failure assessment) 
score to describe organ dysfunction/
failure. On behalf of the working 
group on sepsis-related problems of 
the European Society of Intensive Care 
Medicine. Intensive Care Medicine. 
1996;22(7):707-710
[13] van der Woude SW et al. 
Classifying sepsis patients in the 
emergency department using 
SIRS, qSOFA or MEWS. The 
Netherlands Journal of Medicine. 
2018;76(4):158-166
[14] Seymour CW et al. Assessment of 
clinical criteria for sepsis: For the third 
international consensus definitions 
for sepsis and septic shock (Sepsis-3). 
JAMA. 2016;315(8):762-774
[15] Vaught AJ. Maternal sepsis. 
Seminars in Perinatology. 
2018;42(1):9-12
[16] Larsen FF, Petersen JA. Novel 
biomarkers for sepsis: A narrative 
review. European Journal of Internal 
Medicine. 2017;45:46-50
[17] Takeuchi O, Akira S. Pattern 
recognition receptors and inflammation. 
Cell. 2010;140(6):805-820
[18] Angus DC, van der Poll T. Severe 
sepsis and septic shock. The New 
England Journal of Medicine. 
2013;369(21):2063
[19] Angus DC et al. Epidemiology 
of severe sepsis in the United States: 
Analysis of incidence, outcome, and 
associated costs of care. Critical Care 
Medicine. 2001;29(7):1303-1310
References
Clinical Management of Shock - The Science and Art of Physiological Restoration
14
[20] Opal SM et al. Systemic host 
responses in severe sepsis analyzed 
by causative microorganism and 
treatment effects of drotrecogin alfa 
(activated). Clinical Infectious Diseases. 
2003;37(1):50-58
[21] Dellinger RP et al. Surviving sepsis 
campaign: International guidelines for 
management of severe sepsis and septic 
shock: 2012. Critical Care Medicine. 
2013;41(2):580-637
[22] Mayr FB et al. Infection rate 
and acute organ dysfunction 
risk as explanations for racial 
differences in severe sepsis. JAMA. 
2010;303(24):2495-2503
[23] Hollenberg SM et al. Practice 
parameters for hemodynamic 
support of sepsis in adult patients: 
2004 update. Critical Care Medicine. 
2004;32(9):1928-1948
[24] Rivers E et al. Early goal-directed 
therapy in the treatment of severe 
sepsis and septic shock. The New 
England Journal of Medicine. 
2001;345(19):1368-1377
[25] Paul M et al. Systematic review 
and meta-analysis of the efficacy of 
appropriate empiric antibiotic therapy 
for sepsis. Antimicrobial Agents and 
Chemotherapy. 2010;54(11):4851-4863
[26] Rhodes A et al. Surviving sepsis 
campaign: international guidelines 
for management of sepsis and septic 
shock: 2016. Critical Care Medicine. 
2017;45(3):486-552
[27] Shankar-Hari M et al. Developing 
a new definition and assessing new 
clinical criteria for septic shock: For 
the third international consensus 
definitions for sepsis and septic shock 
(Sepsis-3). JAMA. 2016;315(8):775-787
[28] De Backer D et al. Comparison 
of dopamine and norepinephrine 
in the treatment of shock. The 
New England Journal of Medicine. 
2010;362(9):779-789
[29] Sacha GL, Bauer SR, Lat I.  
Vasoactive agent use in septic shock: 
Beyond first-line recommendations. 
Pharmacotherapy. 2019;39(3):369-381
[30] Say L et al. Global causes of 
maternal death: A WHO systematic 
analysis. The Lancet Global Health. 
2014;2(6):e323-e333
[31] Bamfo JE. Managing the risks 
of sepsis in pregnancy. Best Practice 
& Research. Clinical Obstetrics & 
Gynaecology. 2013;27(4):583-595
[32] Chebbo A et al. Maternal sepsis 
and septic shock. Critical Care Clinics. 
2016;32(1):119-135
[33] Kendle AM, Louis J. Recognition 
and treatment of sepsis in pregnancy. 
Journal of Midwifery & Women's 
Health. 2018;63(3):347-351
[34] Lapinsky SE. Obstetric 
infections. Critical Care Clinics. 
2013;29(3):509-520
[35] Smaill FM, Grivell RM. Antibiotic 
prophylaxis versus no prophylaxis 
for preventing infection after 
cesarean section. Cochrane 
Database of Systematic Reviews. 
2014;10:CD007482
[36] Parfitt SE et al. Sepsis in 
obstetrics: Clinical features and 
early warning tools. MCN: American 
Journal of Maternal Child Nursing. 
2017;42(4):199-205
[37] Muller AE et al. Morbidity related 
to maternal group B streptococcal 
infections. Acta Obstetricia et 
Gynecologica Scandinavica. 
2006;85(9):1027-1037
[38] McIntyre J. Mothers infected 
with HIV. British Medical Bulletin. 
2003;67:127-135
15
Sepsis and Septic Shock
DOI: http://dx.doi.org/10.5772/intechopen.86800
[39] Sriskandan S. Severe peripartum 
sepsis. The Journal of the Royal 
College of Physicians of Edinburgh. 
2011;41(4):339-346
[40] Barton JR, Sibai BM. Severe 
sepsis and septic shock in pregnancy. 
Obstetrics and Gynecology. 
2012;120(3):689-706
[41] Angus DC et al. A systematic 
review and meta-analysis of early 
goal-directed therapy for septic shock: 
The ARISE, ProCESS and ProMISe 
investigators. Intensive Care Medicine. 
2015;41(9):1549-1560
[42] Raghunathan K et al. Association 
between the choice of IV crystalloid and 
in-hospital mortality among critically 
ill adults with sepsis. Critical Care 
Medicine. 2014;42(7):1585-1591
[43] Acker SN et al. Head injury and 
unclear mechanism of injury: Initial 
hematocrit less than 30 is predictive 
of abusive head trauma in young 
children. Journal of Pediatric Surgery. 
2014;49(2):338-340
[44] Ames SG et al. Infectious etiologies 
and patient outcomes in pediatric septic 
shock. Journal of the Pediatric Infectious 
Diseases Society. 2017;6(1):80-86
[45] Alder MN, Opoka AM, Wong HR.  
The glucocorticoid receptor and cortisol 
levels in pediatric septic shock. Critical 
Care. 2018;22(1):244
[46] Syngal P, Giuliano JS Jr. Health-
related quality of life after pediatric 
severe sepsis. Healthcare (Basel). 
2018;6(3):1-7
[47] Marshall JC. Understanding the 
global burden of pediatric sepsis. 
American Journal of Respiratory 
and Critical Care Medicine. 
2015;191(10):1096-1098
[48] Watson RS et al. The epidemiology 
of severe sepsis in children in the 
United States. American Journal of 
Respiratory and Critical Care Medicine. 
2003;167(5):695-701
[49] Mathias B, Mira JC, Larson SD.  
Pediatric sepsis. Current Opinion in 
Pediatrics. 2016;28(3):380-387
[50] Watson RS, Carcillo JA. Scope 
and epidemiology of pediatric sepsis. 
Pediatric Critical Care Medicine. 
2005;6(3 Suppl):S3-S5
[51] Goldstein B et al. International 
pediatric sepsis consensus conference: 
Definitions for sepsis and organ 
dysfunction in pediatrics. Pediatric 
Critical Care Medicine. 2005;6(1):2-8
[52] Ruth A et al. Pediatric severe 
sepsis: Current trends and outcomes 
from the pediatric health information 
systems database. Pediatric Critical Care 
Medicine. 2014;15(9):828-838
